Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Risperidone Long-acting injectable (LAI) suspension bulk supplier for pharma manufacturers

Risperidone Long-Acting Injectable (Lai) Suspension Suppliers & Bulk Manufacturers

Available Forms: Long-acting injectable (LAI) suspension

Available Strengths: 25 mg, 37.5 mg, 50 mg per dose

Reference Brands: Risperdal®(US & EU); EU: Risperidon-ratiopharm®, Rispolept®, Rispen®

Category: Antipsychotropic Drugs

Risperidone long-acting injection is an antipsychotic given every two weeks or monthly for schizophrenia and bipolar disorder, so patients do not need daily tablets. The original product, Risperdal Consta (25 to 50 mg microspheres), needs cold-chain storage at 2–8 °C. Newer monthly forms are given under the skin. Ask PharmaTradz for a quote; we confirm the manufacturer, registration documents and lead time for your country.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Risperidone Long-Acting Injectable (Lai) Suspension? List it or send an offer →

Product Description:

Risperidone Long-Acting Injectable (LAI) suspension is approved by the FDA in the United States and the EMA in the European Union for the treatment of schizophrenia and maintenance therapy in bipolar I disorder. It offers an extended-release formulation designed for intramuscular injection every two weeks or monthly, ensuring steady therapeutic levels and improving medication adherence. Regulatory bodies emphasize its importance in reducing relapse rates and hospitalizations. Prescribers must adhere to initiation protocols, especially when transitioning from oral risperidone. To explore additional forms and strengths of risperidone LAI, visit Pharmatradz.com.

Risperidone Long-Acting Injectable (Lai) Suspension — third party manufacturing & bulk supply

Risperidone Long-Acting Injectable (Lai) Suspension is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Risperidone Long-Acting Injectable (Lai) Suspension is supplied as Long-acting injectable (LAI) suspension — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Risperidone Long-Acting Injectable (Lai) Suspension listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Risperidone Long-Acting Injectable (Lai)... →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Risperidone injection is used for the treatment of schizophrenia and sometimes bipolar disorder. Long-acting formulations are given to patients who need consistent antipsychotic treatment and may have difficulty taking daily oral medication. It helps control symptoms such as hallucinations, delusions, mood changes, and disorganized thinking.

Risperidone injection is made from the active pharmaceutical ingredient risperidone, an atypical antipsychotic compound that works by affecting dopamine and serotonin receptors in the brain. Long-acting injectable versions use specialized delivery systems that release the medicine slowly over time.

The main trade names include Risperdal Consta, Perseris, Uzedy, and Rykindo, along with several regional brand names depending on the country and manufacturer.

Risperdal Consta is manufactured by Janssen Pharmaceuticals (a Johnson & Johnson company). Perseris is produced by Indivior. Uzedy is developed by Teva Pharmaceuticals in collaboration with Medincell. Rykindo is produced by Luye Pharma Group. In India and other markets, various pharmaceutical manufacturers produce risperidone long-acting injections under licensed or local brands.

The generic name is risperidone.

Major brand names include Risperdal Consta, Perseris, Uzedy, and Rykindo.

Risperidone injections are manufactured in multiple countries depending on the brand, including the United States, European Union countries, China, and India, under approved pharmaceutical manufacturing facilities that comply with regulatory standards such as US FDA, EMA, and other national authorities.

The microspheres in Risperdal Consta must be stored at 2–8 °C; they can be kept at room temperature for up to seven days before use.

Risperdal Consta (intramuscular every two weeks), Perseris and Uzedy (monthly or two-monthly under the skin), and Rykindo. Each has its own dosing schedule.

Generic versions are limited because the microsphere technology is complex; registration needs a full complex-generic dossier, so we confirm what is approved for your market.

Related Products

Risperidone Oral Solution

Strength:
1 mg/mL

Form: Oral solution

Reference Brands: Risperdal® (EU & US)

View Details
Risperidone Tablets

Strength:
0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg

Form: Tablets

Reference Brands: Risperdal®(US & EU); EU: Risperidon-ratiopharm®, Rispolept®, Rispen® '

View Details
Prochlorperazine Maleate Tablet

Strength:
5 mg, 10 mg

Form: Tablet

Reference Brands: US: Compazine®, Procomp®; EU: Stemetil®, Buccastem®

View Details
Prochlorperazine Maleate Buccal Tablets

Strength:
3 mg

Form: Buccal tablets

Reference Brands: US: Compazine®, Procomp®; EU: Stemetil®, Buccastem®

View Details
Haloperidol Injection

Strength:
5 mg/mL

Form: Injection (IM/IV)

Reference Brands: Haldol®(US)

View Details
Haloperidol Oral Solution

Strength:
2 mg/mL

Form: Oral Solution

Reference Brands: Haldol(US)

View Details
Chlorpromazine Tablets

Strength:
10 mg, 25 mg, 50 mg, 100 mg, 200 mg

Form: Oral Tablets

Reference Brands: Thorazine®(US); Largactil®(EU)

View Details
Chlorpromazine Syrup

Strength:
30 mg/mL

Form: Oral Syrup

Reference Brands: Largactil® (EU); Thorazine®(US)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us